Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ADCT will decline by -59.52% over the next 2 Weeks and hit $0.52 by Wednesday, July 22, 2026. In that time frame, ADCT's share price is expected to range between $0.00 and $1.34.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jul 22, 2026 | 0.00 | 0.52 | 1.34 |
| Jul 21, 2026 | 0.00 | 0.42 | 1.16 |
| Jul 20, 2026 | 0.00 | 0.58 | 1.26 |
| Jul 17, 2026 | 0.00 | 0.55 | 1.24 |
| Jul 16, 2026 | 0.00 | 0.72 | 1.42 |
| Jul 15, 2026 | 0.21 | 0.94 | 1.70 |
| Jul 14, 2026 | 0.10 | 0.84 | 1.54 |
| Jul 13, 2026 | 0.29 | 1.00 | 1.74 |
| Jul 10, 2026 | 0.24 | 0.98 | 1.76 |
| Jul 9, 2026 | 0.39 | 1.15 | 1.85 |
ADCT shares fell -5.19% in Wednesday, July 8, 2026's trading session, dropping from a previous close of $1.35 to move at $1.28. The stock demonstrated notable intraday movement (see ADCT's key stats for a full breakdown), fluctuating between $1.28 and $1.37, a +7.40% trading range. While recent weeks have seen some volatility, ADCT has managed to secure a +19.63% gain over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 1.83M shares changing hands, 1.3M fewer than the previous session. This amounted to $2.34M in total market activity.
Will ADCT Continue Its Upward Trend?
According to analyst ratings and projections for ADCT, ADC Therapeutics S.A. shares are anticipated to increase by +4.81%, potentially reaching $1.34 per share by July 22, 2026. Short-term technical indicators for ADCT currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 19 negative trading days within the past 30 sessions. Based on the ADCT stock forecast, now is a good time to buy ADCT stock because its current trading price is +147.06% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on ADCT covering social and institutional perspectives.
ADCT Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ADCT's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 33.23% to 48.00%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 35.92%, hints at potential weakness developing in the medium term. Meanwhile, the 100-day RSI, at 41.81%, maintains a neutral outlook for the long term. Insights into ADCT's shareholder base show how institutional investors are positioning themselves during these momentum shifts
ADC Therapeutics SA Short-Term Forecasts
ADCT Forecast For Next 5 Days
Our algorithm anticipates ADC Therapeutics SA (ADCT) stock could hit $0.84 by Jul 16, 2026. This represents a -34.45% fall from today's price, following a -7.85% change over the past five days.
ADCT Forecast For Next 30 Days
Based on analysis of market trends, the outlook for ADC Therapeutics S.A. (ADCT) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.56, which would mean a -56.25% decrease from the current price of $1.28. Projections for this period range from a high of $1.67 to a low of $0.00.
ADCT Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for ADC Therapeutics SA's price over the next three months point to a rise. ADCT stock is expected to peak at $6.36 on Jul 20, 2026 before potentially dipping to $3.33 on Oct 09, 2026. On average, ADCT is likely to trade around $4.94 in the coming 90 days.
ADC Therapeutics SA Stock Forecast 2025
Based on our predictive models, ADC Therapeutics SA (ADCT) is expected to trade between $0.17 and $6.36 throughout 2026. This would result in an average price of $3.84, potentially offering investors a +200.00% return from current levels.
ADC Therapeutics S.A. Monthly Forecast 2026–2027
July 2026
According to our latest forecast models, ADC Therapeutics S.A. (ADCT) is positioned to show a strong performance in July 2026. The price is predicted to move between $5.42 and $6.36, settling at an average of $5.94. This could translate to a +364.06% gain.
August 2026
Based on current market signals, ADC Therapeutics S.A. is projected to trend august 2026. We forecast a trading range from $4.23 to $5.80, with a likely average price of $5.10. Investors could expect a potential return of +298.44%.
September 2026
Our predictive algorithms indicate ADC Therapeutics S.A. stock may see a shift in September 2026. The expected range spans $3.43–$4.58, with an average target of $4.32. This represents a positive outlook and a possible gain of +237.50%.
October 2026
Analyzing established trends, ADC Therapeutics S.A. looks set to move in October 2026. Projections place the stock between $2.24 and $4.12, averaging around $3.72. This suggests a +190.63% gain from current levels.
November 2026
Market indicators suggest ADC Therapeutics S.A. could experience notable changes during November 2026. Prices could fluctuate within $1.07 to $2.82, with a midpoint forecast of $2.46. The stock might deliver a +92.19% gain.
December 2026
Forecasting for December 2026, models estimate that ADC Therapeutics S.A. may undergo key fluctuations. If trends hold, the stock might trade between $0.17 and $2.01, averaging $2.08. This signals a positive trajectory with potential returns around +62.50%.
January 2027
According to our latest forecast models, ADC Therapeutics S.A. (ADCT) is positioned to show a strong performance in January 2027. The price is predicted to move between $0.00 and $1.68, settling at an average of $2.17. This could translate to a +69.53% gain.
February 2027
Based on current market signals, ADC Therapeutics S.A. is projected to trend february 2027. We forecast a trading range from $0.00 to $1.07, with a likely average price of $2.35. Investors could expect a potential return of +83.59%.
March 2027
Our predictive algorithms indicate ADC Therapeutics S.A. stock may see a shift in March 2027. The expected range spans $0.00–$0.28, with an average target of $1.84. This represents a positive outlook and a possible gain of +43.75%.
April 2027
Analyzing established trends, ADC Therapeutics S.A. looks set to move in April 2027. Projections place the stock between $0.00 and $0.00, averaging around $1.29. This suggests a +0.78% gain from current levels.
May 2027
Market indicators suggest ADC Therapeutics S.A. could experience notable changes during May 2027. Prices could fluctuate within $0.00 to $0.00, with a midpoint forecast of $1.02. The stock might deliver a -20.31% loss.
June 2027
Forecasting for June 2027, models estimate that ADC Therapeutics S.A. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.00, averaging $0.71. This signals a cautious trajectory with potential returns around -44.53%.
July 2027
According to our latest forecast models, ADC Therapeutics S.A. (ADCT) is positioned to show a strong performance in July 2027. The price is predicted to move between $0.00 and $0.00, settling at an average of $0.56. This could translate to a -56.25% loss.
ADCT's history of dividends and stock splits also plays a role in long-term investor confidence.